Piccina Cintia — SEC insider filings

SEC reporting owner CIK 1907199. 10 insider filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 10 filings on record, filed 2022-01-31 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adaptimmune Therapeutics PLC (ADAP)Chief Commercial Officer8—4 legs · 70,452 sh · $89,82510
Autolus Therapeutics plc (AUTL)U.S. CCO & Country Gen Manager1—1 leg · 6,713 sh · $15,6822
Allovir, Inc. (ALVR)Chief Commercial Officer1——2

Insider filings — Piccina Cintia

FiledFormIssuerReported transactionsSource
2026-09-034Autolus Therapeutics plc (AUTL)Option exercise (M): 20,000 @ $2.35 · Sale (S): 6,713 @ $2.34 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2025-02-204Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 1,612,032 (derivative) @ $0 · Grant/award (A): 1,074,696 (derivative) @ $0EDGAR
2025-01-154Adaptimmune Therapeutics PLC (ADAP)Sale (S): 12,991 @ $0.57EDGAR
2024-06-184Adaptimmune Therapeutics PLC (ADAP)Sale (S): 24,531 @ $0.93EDGAR
2024-03-184Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 5,088,864 (derivative) @ $0 · Grant/award (A): 1,130,832 (derivative) @ $0EDGAR
2023-07-054Allovir, Inc. (ALVR)Grant/award (A): 147,000 @ $0 · Grant/award (A): 273,000 (derivative) @ $0EDGAR
2023-01-314Adaptimmune Therapeutics PLC (ADAP)Sale (S): 11,890 @ $1.87EDGAR
2023-01-174Adaptimmune Therapeutics PLCGrant/award (A): 1,407,072 (derivative) @ $0 · Grant/award (A): 314,256 (derivative) @ $0 · Grant/award (A): 181,560 (derivative) @ $0EDGAR
2022-08-014Adaptimmune Therapeutics PLC (ADAP)Sale (S): 21,040 @ $1.77EDGAR
2022-01-314Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 3,376,992 (derivative) @ $0 · Grant/award (A): 754,200 (derivative) @ $0 · Grant/award (A): 335,184 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1907199 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs